IDEAYA Biosciences IDYA
NASDAQ IDYA
$39.77 -0.20 (-0.50%)
As of: Sep 4, 2026 · 2:26 PM EDT

IDEAYA Biosciences (IDYA) Operating Margin Growth (1y) (2021 - 2025)

Analysis

IDEAYA Biosciences (IDYA) Operating Margin Growth (1y) (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 78.00
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 1,135.00
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 7,666.00
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 1,238.00
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 2,002.00
8 Royalty Pharma 28.41 Bn 27.57 Bn - -1,651.00
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 29,091.00
10 IDEAYA Biosciences 3.66 Bn 2.83 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 118,959.00
Dec 31, 2024 -99,035.00
Dec 31, 2023 -41,131.00
Sep 30, 2023 -41,932.00
Jun 30, 2023 -53,841.00
Mar 31, 2023 -20,830.00
Dec 31, 2022 -3,730.00
Sep 30, 2022 13,271.00
Jun 30, 2022 -25,832.00
Mar 31, 2022 87.00
Dec 31, 2021 -57,021.00
Sep 30, 2021 -7,478.00